Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Large-Scale HLA Tetramer Tracking of T Cells during Dengue Infection Reveals Broad Acute Activation and Differentiation into Two Memory Cell Fates.

Chng MHY, Lim MQ, Rouers A, Becht E, Lee B, MacAry PA, Lye DC, Leo YS, Chen J, Fink K, Rivino L, Newell EW.

Immunity. 2019 Nov 13. pii: S1074-7613(19)30451-0. doi: 10.1016/j.immuni.2019.10.007. [Epub ahead of print]

PMID:
31757672
2.

Mass cytometry: a powerful tool for dissecting the immune landscape.

Simoni Y, Chng MHY, Li S, Fehlings M, Newell EW.

Curr Opin Immunol. 2018 Apr;51:187-196. doi: 10.1016/j.coi.2018.03.023. Epub 2018 Apr 11. Review.

PMID:
29655022
3.

Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Ghazarian M, Revelo XS, Nøhr MK, Luck H, Zeng K, Lei H, Tsai S, Schroer SA, Park YJ, Chng MHY, Shen L, D'Angelo JA, Horton P, Chapman WC, Brockmeier D, Woo M, Engleman EG, Adeyi O, Hirano N, Jin T, Gehring AJ, Winer S, Winer DA.

Sci Immunol. 2017 Apr 21;2(10). pii: eaai7616. doi: 10.1126/sciimmunol.aai7616.

4.

High-fat diet induces systemic B-cell repertoire changes associated with insulin resistance.

Pham TD, Chng MHY, Roskin KM, Jackson KJL, Nguyen KD, Glanville J, Lee JY, Engleman EG, Boyd SD.

Mucosal Immunol. 2017 Nov;10(6):1468-1479. doi: 10.1038/mi.2017.25. Epub 2017 Apr 19.

PMID:
28422186
5.

Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance.

Revelo XS, Ghazarian M, Chng MH, Luck H, Kim JH, Zeng K, Shi SY, Tsai S, Lei H, Kenkel J, Liu CL, Tangsombatvisit S, Tsui H, Sima C, Xiao C, Shen L, Li X, Jin T, Lewis GF, Woo M, Utz PJ, Glogauer M, Engleman E, Winer S, Winer DA.

Cell Rep. 2016 Jul 19;16(3):717-30. doi: 10.1016/j.celrep.2016.06.024. Epub 2016 Jun 30.

6.

Adaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance.

Chng MH, Alonso MN, Barnes SE, Nguyen KD, Engleman EG.

Mediators Inflamm. 2015;2015:593075. doi: 10.1155/2015/593075. Epub 2015 Jun 4. Review.

7.

Regulation of obesity-related insulin resistance with gut anti-inflammatory agents.

Luck H, Tsai S, Chung J, Clemente-Casares X, Ghazarian M, Revelo XS, Lei H, Luk CT, Shi SY, Surendra A, Copeland JK, Ahn J, Prescott D, Rasmussen BA, Chng MH, Engleman EG, Girardin SE, Lam TK, Croitoru K, Dunn S, Philpott DJ, Guttman DS, Woo M, Winer S, Winer DA.

Cell Metab. 2015 Apr 7;21(4):527-42. doi: 10.1016/j.cmet.2015.03.001.

8.

B-1a lymphocytes attenuate insulin resistance.

Shen L, Chng MH, Alonso MN, Yuan R, Winer DA, Engleman EG.

Diabetes. 2015 Feb;64(2):593-603. doi: 10.2337/db14-0554. Epub 2014 Sep 23.

9.

Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region.

Tan AT, Sodsai P, Chia A, Moreau E, Chng MH, Tham CY, Ho ZZ, Banu N, Hirankarn N, Bertoletti A.

J Virol. 2014 Jan;88(2):1332-41. doi: 10.1128/JVI.02600-13. Epub 2013 Nov 13.

10.

B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.

Winer DA, Winer S, Chng MH, Shen L, Engleman EG.

Cell Mol Life Sci. 2014 Mar;71(6):1033-43. doi: 10.1007/s00018-013-1486-y. Epub 2013 Oct 15. Review.

11.

B lymphocytes as emerging mediators of insulin resistance.

Winer DA, Winer S, Shen L, Chng MH, Engleman EG.

Int J Obes Suppl. 2012 Jul;2(Suppl 1):S4-S7.

Supplemental Content

Support Center